Federico Feldstein currently leads the BioResearch Quality & Compliance (BRQC) organization across the three sectors (Pharmaceutical, Medical Device, Consumer Health) at Johnson & Johnson. He is a member of the Johnson & Johnson Quality & Compliance Leadership Team, Janssen Quality & Compliance Leadership Team, Janssen Research & Development Leadership Team, and Janssen Global Development Leadership Team.

In this position, Federico is responsible for driving the strategic direction of BRQC to deliver oversight of and drive adherence to Good Laboratory Practice (GLP), Good Clinical Practice (GCP), and Pharmacovigilance (GVP). Federico is also responsible for overseeing the Quality organization for the Vaccines Development. Federico has been with Johnson & Johnson since 2015 and assumed his current role as Global Head of BRQC in 2017. Since then, he has led the team’s cross-sector evolution to optimize the way R&D Quality operates to deliver sustained excellence, maximize productivity, and to better serve the R&D portfolio. Federico is a board member of the Hispanic Resource Group and actively engaged with the development and implementation of strategies for increasing diversity across Supply Chain and R&D.

Prior to joining Johnson & Johnson, Federico spent 20+ years at Pfizer where he served as Vice President, Medical Regulatory Compliance, and in a number of executive positions, including leading Medical R&D Innovative Pharmaceutical Quality, Preclinical & Consumer Quality. He has extensive experience in innovating and simplifying systems and procedures to assure quality oversight in clinical trials and data integrity in product submissions.

Federico holds a Bachelor of Science degree in Zoology and a Juris Doctor. He lives in New Jersey with his wife and three children and enjoys soccer / fútbol and cycling in his spare time.